Nurse practitioners; authorize to dispense legend drugs to patients.
Summary
SB2667 amends Mississippi’s advanced practice registered nurse statute to expressly authorize nurse practitioners to dispense legend drugs or medications to their own patients, so long as the nurse practitioner already has prescriptive authority and the drug is not a controlled substance. The bill also makes a conforming change to align the statute with the Mississippi Medical Cannabis Act by clarifying that nurse practitioners may not prescribe, dispense, or order controlled substances except as otherwise allowed under that act or existing law.
The measure leaves in place the existing framework for APRN practice, including collaboration or consultation with a physician or dentist, board-approved protocols or practice guidelines, continuing education, renewal, reinstatement, and disciplinary standards. It also preserves the separate process by which certified nurse practitioners and certified nurse midwives may seek controlled-substance prescriptive authority after completing a board-approved educational program, including authority to prescribe Schedules II-V if approved by the board. The act takes effect July 1, 2025.
Impact
The bill would amend Section 73-15-20 of the Mississippi Code, expanding the dispensing authority of nurse practitioners by allowing them to dispense legend drugs or medications to their patients, while maintaining the prohibition on dispensing controlled substances except as otherwise authorized by law. It would also require the Mississippi Board of Nursing to continue regulating APRN practice through protocols, rules, and disciplinary enforcement, and it updates the statute to conform to the Mississippi Medical Cannabis Act. The practical effect is to broaden nurse practitioner practice authority in medication access and dispensing, while leaving the overall collaborative practice structure intact.
Sentiment
Based on the bill text and available context, the measure appears to be a targeted professional-practice expansion with a regulatory rather than ideological focus. There are no recorded committee transcripts or votes in the provided materials, so there is no documented public debate to indicate strong support or opposition. The caption and drafting suggest the bill is intended to clarify and modernize nurse practitioner authority rather than make a sweeping policy change.
Contention
The main point of potential contention is the scope of nurse practitioner authority to dispense medications without a separate physician or pharmacy role, especially in light of existing controlled-substance restrictions. Any concern would likely center on patient safety, oversight, and whether dispensing authority should be limited to certain settings or protocols. Another possible issue is the interaction with the Mississippi Medical Cannabis Act, since the bill explicitly preserves existing cannabis-related exceptions while otherwise maintaining the controlled-substance ban for nurse practitioners.